Lv1
80 积分 2023-11-01 加入
Association of QTc Formula With the Clinical Management of Patients With Cancer
7个月前
已完结
Adjuvant Treatments for Surgically Resected Non–Small Cell Lung Cancer Harboring EGFR Mutations
7个月前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
7个月前
已完结
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E
7个月前
已完结
EP08.02-140 MET Biomarker-based Preliminary Efficacy Analysis in SAVANNAH: savolitinib+osimertinib in EGFRm NSCLC Post-Osimertinib
7个月前
已关闭
2MO Final OS results and subgroup analysis of savolitinib in patients with MET exon 14 skipping mutations (METex14+) NSCLC
7个月前
已关闭
Final OS results and subgroup analysis of savolitinib in patients with MET exon 14 skipping mutations (METex14+) NSCLC
7个月前
已关闭
非小细胞肺癌MET临床检测中国专家共识
7个月前
已完结
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2021
7个月前
已关闭
皖公网安备34019202002308
